Device Cos. Slam FDA's Overseas Clinical Trial Rule
A U.S. Food and Drug Administration proposal to strengthen oversight of overseas clinical trials involving medical devices ignores barriers presented by other countries' laws and applies stricter rules than exist on...To view the full article, register now.
Already a subscriber? Click here to view full article